StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 12/05/2013 -- StockRunway.com issues special report on – Horizon Pharma Inc(NASDAQ:HZNP), OmniVision Technologies, Inc.(NASDAQ:OVTI), CYS Investments Inc(NYSE:CYS), Dynavax Technologies Corporation(NASDAQ:DVAX)
Horizon Pharma Inc(NASDAQ:HZNP) stock is at $6.93, down -3.08percent from its previous close of $7.15. The stock opened the session at $7.12and touched its highest price point at $7.15.
Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive with +172.83% during previous three months trade. Its recent trading volume was 1.27 million shares in comparison to its usual trading volume of 1.68 million shares. Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications.
Has HZNP Found The Bottom and Ready To Move Up? Find Out Here
OmniVision Technologies, Inc.(NASDAQ:OVTI) stock is at $15.52, down -2.94 percent from its previous close of $2.94. Its today’s volume is 7.88million shares in comparison to its usual trading volume of 1.18 million shares. The stock opened the session at 14.35 and touched its highest price point at $15.93.
OVTI’s quarterly performance remained red with the percentage of -0.06, while its year to date performance showed that the stock advanced overall +10.23%. OmniVision Technologies, Inc. engages in designing, developing, and marketing semiconductor image-sensor devices worldwide.
Has OVTI Found The Bottom And Ready To Gain Momentum? Find Out Here
CYS Investments Inc(NYSE:CYS) experienced a plunge of -2.84% to a market valuation of $1.25B per share for previous trading session. After opening the day at $7.63 per share, volume surged to 4.87 million.
During last one month it slipped with the percentage of -11.43. Its year to date performance remained adverse with -36.33%. CYS Investments, Inc., a specialty finance company, invests in residential mortgage pass-through certificates in the United States.
Why Should Investors Buy CYS After the Recent Fall? Just Go Here and Find Out
Dynavax Technologies Corporation(NASDAQ:DVAX) opened its shares at the price of $1.76 for the day, its closing price was $1.73 after losing -2.81% for the day. The company traded with the total volume of 3.07 million shares while its average trading aptitude remained 5.27 million shares. The company has total of 262.63 million outstanding shares and its total market capitalization is $454.34 million. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences. Its lead product candidate is HEPLISAV, a Phase III investigational adult hepatitis B vaccine.
Will DVAX Get Buyers Even After The Recent Rally? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)